HSD17B13 anticorps (AA 1-200)

N° du produit ABIN7868558

Cet anticorps Souris Monoclonal détecte spécifiquement HSD17B13 dans IHC (p). Il présente une réactivité avec des échantillons de Humain.

Aperçu rapide pour HSD17B13 anticorps (AA 1-200) (ABIN7868558)

Antigène: HSD17B13 (Hydroxysteroid (17-Beta) Dehydrogenase 13 (HSD17B13))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp HSD17B13 est non-conjugé

Application: Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Classe de qualité: Carrier-free

Clone: HSD17B13-13102

Détail du produit anti-HSD17B13 anticorps

Épitope: AA 1-200

Fonction: HSD17B13 Antibody / 7-beta hydroxysteroid dehydrogenase 13 (azide and preservative free)

Purification: Protein G affinity

Immunogène: A portion of amino acids 1-200 of the human protein was used as the immunogen for the HSD17B13 antibody.

Isotype: IgG2b, kappa

Information d'application

Indications d'application: Optimal dilution of the HSD17B13 antibody should be determined by the researcher.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: 1 mg/mL in 1X PBS, BSA free, sodium azide free

Agent conservateur: Azide free

Stock: -20 °C

Stockage commentaire: Aliquot the HSD17B13 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.

Détails sur HSD17B13

Antigène: HSD17B13 (Hydroxysteroid (17-Beta) Dehydrogenase 13 (HSD17B13))

Autre désignation: HSD17B13

Sujet: Hydroxysteroid 17-beta dehydrogenase 13 (HSD17B13) is an enzyme in the liver that is associated with lipid droplets. It is encoded by the HSD17B13 gene in humans. HSD17B13 levels increase in patients with non-alcoholic fatty liver disease (NAFLD) and can enhance lipogenesis. However, some studies have shown that loss-of-function variants in HSD17B13 may protect against the progression of NAFLD to non-alcoholic steatohepatitis, fibrosis, and hepatocellular carcinoma.

UniProt: Q7Z5P4